Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Nutr Neurosci ; 25(5): 990-1000, 2022 May.
Article in English | MEDLINE | ID: mdl-33023416

ABSTRACT

Mitochondrial energetic deficit is one of the hallmarks of neurodegenerative disorders, e.g. Alzheimer´s disease (AD). Adherence to a Mediterranean diet is associated with lower incidence of cognitive decline and AD and extra virgin olive oil's (poly)phenols such as oleuropein and hydroxytyrosol (HT) are being actively studied in this respect. In this study, we assessed the effects of HT on mitochondrial energetic dysfunction in the 7PA2 cells cellular model, i.e. one of the best cellular models of Aß toxicity with a well-characterized mitochondrial dysfunction typically observed in AD. We report an increase of new mitochondria at 8 h post HT-treatment, which was followed by higher mitochondrial fusion. Further, ATP concentrations were significantly increased after 24 h of treatment with HT as compared with controls. Our data suggest that HT may revert the energetic deficit of a cellular model of AD by potentiating mitochondrial activity. Because HT is being proposed as dietary supplement or component of functional foods, future studies in appropriate animal models and - eventually - humans are warranted to further investigate its potential neuroprotective actions in AD.


Subject(s)
Alzheimer Disease , Phenylethyl Alcohol , Animals , Mitochondria , Phenylethyl Alcohol/analogs & derivatives
3.
Diagn Microbiol Infect Dis ; 85(4): 490-2, 2016 Aug.
Article in English | MEDLINE | ID: mdl-27220606

ABSTRACT

Human infections caused by Streptococcus lactarius have not been previously reported. In the present report, we describe a lactational mastitis caused by this organism. The infection occurred in a 28-year-old breast-feeding female, with a 10-days history of moderate pain on the right breast. The patient was cured after antibiotic treatment with levofloxacin for 21 days. Our case shows that S. lactarius should be considered as a cause of lactational mastitis. The introduction of molecular microbiology techniques can be extremely useful for knowing the implication of streptococci in lactational mastitis.


Subject(s)
Mastitis/etiology , Mastitis/pathology , Streptococcal Infections/diagnosis , Streptococcal Infections/pathology , Streptococcus/classification , Streptococcus/isolation & purification , Adult , Anti-Bacterial Agents/therapeutic use , Female , Humans , Levofloxacin/therapeutic use , Mastitis/drug therapy , Mastitis/microbiology , Molecular Diagnostic Techniques , Streptococcal Infections/drug therapy , Streptococcal Infections/microbiology , Treatment Outcome
4.
Diagn Microbiol Infect Dis ; 79(1): 108-10, 2014 May.
Article in English | MEDLINE | ID: mdl-24582579

ABSTRACT

Cupriavidus gilardii is a rare cause of human infection. We report a muscular abscess on the right thigh caused by this organism in a renal transplant recipient, who had suffered a septic shock associated with an extensive cellulitis caused by Streptococcus pyogenes. The patient was successfully treated with surgical drainage and intravenous ciprofloxacin for 13 days. This is the first time that C. gilardii is isolated from a human abscess. C. gilardii should be considered as a cause of human infection, especially in immunocompromised patients. Infection caused by this organism may be underdiagnosed because the identification is very difficult.


Subject(s)
Cupriavidus/isolation & purification , Gram-Negative Bacterial Infections/microbiology , Kidney Transplantation , Psoas Abscess/microbiology , Transplant Recipients , Adult , Humans , Male
5.
Anaerobe ; 27: 14-6, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24631671

ABSTRACT

We report the first case of Fournier's gangrene caused by three unusual anaerobic organisms: Actinomyces funkei, Fusobacterium gonidiaformans and Clostridium hathewayi. The infection occurred in a 73-year-old man without typical risk factors for the development of Fournier's gangrene. Clinical outcome was good after prolonged antibiotic treatment and extensive debridement of the perineum. The case suggests that A. funkei, F. gonidiaformans and C. hathewayi should be considered as potential pathogens of Fournier's gangrene. Human infections caused by these organisms are very rare but can be underestimated because correct identification is very difficult, especially in polymicrobial infections such as Fournier's gangrene.


Subject(s)
Actinomyces/isolation & purification , Bacterial Infections/diagnosis , Bacterial Infections/pathology , Clostridium/isolation & purification , Fournier Gangrene/diagnosis , Fournier Gangrene/pathology , Fusobacterium/isolation & purification , Aged , Anti-Bacterial Agents/therapeutic use , Bacterial Infections/microbiology , Bacterial Infections/therapy , Debridement , Fournier Gangrene/microbiology , Fournier Gangrene/therapy , Humans , Male
6.
Anaerobe ; 27: 27-30, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24657157

ABSTRACT

Bifidobacterium spp. rarely causes human infections. We report a case of a 42-year-old man with a history of pancolonic diverticulosis, who suffered a purulent peritonitis caused by Bifidobacterium longum secondary to intestinal perforation. Clinical outcome was good after urgent surgery and antibiotic treatment with imipenem and amoxicillin/clavulanic acid. Our case shows that Bifidobacterium spp. should be considered as a cause of peritonitis, especially in patients with risk of intestinal perforation. The review of the literature shows that these organisms can cause a wide spectrum of severe infections, especially in patients with underlying diseases. Infections caused by Bifidobacterium spp. may be overlooked or underreported since it may be considered normal microbiota.


Subject(s)
Bifidobacteriales Infections/diagnosis , Bifidobacteriales Infections/pathology , Bifidobacterium/isolation & purification , Intestinal Perforation/complications , Peritonitis/diagnosis , Peritonitis/pathology , Adult , Anti-Bacterial Agents/therapeutic use , Bifidobacteriales Infections/microbiology , Bifidobacteriales Infections/therapy , Humans , Intestinal Perforation/therapy , Male , Peritonitis/microbiology , Peritonitis/therapy , Surgical Procedures, Operative/methods , Treatment Outcome
7.
Scand J Infect Dis ; 46(2): 130-5, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24325336

ABSTRACT

BACKGROUND: Skin and soft tissue infections (SSTIs) caused by Achromobacter xylosoxidans are very infrequent. The aim of the present study was to investigate the clinical and microbiological characteristics of this infection. METHODS: We carried out a retrospective review of 14 cases of SSTI due to A. xylosoxidans that occurred at the University Hospital of Guadalajara (Spain) from January 2007 to December 2012. RESULTS: The infection was secondary to vascular diseases, trauma, and recent surgery in 12 patients (85.7%). The most frequent clinical presentation was infection of a vascular ulcer (5 cases). The infection was monomicrobial in 7 patients (50%) and 9 cases were community-acquired (64.2%). The clinical outcome of the patients was uniformly good after antibiotic treatment, except in 4 patients who suffered recurrence of the infection. CONCLUSION: A. xylosoxidans should be considered a potential pathogen in patients with SSTIs, especially in patients with vascular diseases or after surgery or trauma. A history of contact with water should be investigated in all cases. Treatment can be difficult due to the high level of antibiotic resistance. Trimethoprim-sulfamethoxazole may be useful for treatment in outpatients with community-acquired infections.


Subject(s)
Achromobacter denitrificans/isolation & purification , Gram-Negative Bacterial Infections/microbiology , Skin Diseases, Bacterial/microbiology , Soft Tissue Infections/microbiology , Adolescent , Adult , Aged , Aged, 80 and over , Anti-Bacterial Agents/therapeutic use , Gram-Negative Bacterial Infections/diagnosis , Gram-Negative Bacterial Infections/drug therapy , Gram-Negative Bacterial Infections/pathology , Hospitals, University , Humans , Middle Aged , Retrospective Studies , Skin Diseases, Bacterial/diagnosis , Skin Diseases, Bacterial/drug therapy , Skin Diseases, Bacterial/pathology , Soft Tissue Infections/diagnosis , Soft Tissue Infections/drug therapy , Soft Tissue Infections/pathology , Spain , Treatment Outcome , Young Adult
8.
Diagn Microbiol Infect Dis ; 76(4): 510-2, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23886436

ABSTRACT

Lactobacillus spp. rarely causes human disease. We report a case of a 57-year-old man with non-insulin-dependent diabetes and vascular disease admitted to our hospital with severe abdominal pain and fever. Signs of peritonitis were found upon examination. The patient underwent surgery, and a diagnosis of perforated cholecystitis with purulent peritonitis was made intra-operatively. A cholecystectomy was performed, and therapy with imipenem was initiated. Lactobacillus plantarum was isolated from bile and peritoneal fluid cultures 2 days later. The patient recovered well and was discharged on post-operative day 16 after 14 days of treatment with imipenem. To our knowledge, this is the second case reported of acute cholecystitis caused by Lactobacillus spp. This organism should be considered as a cause of biliary infections, especially in patients with underlying diseases. Correct identification is often difficult, but it is very important because these organisms are usually resistant to vancomycin and other antibiotics.


Subject(s)
Acalculous Cholecystitis/complications , Diabetes Mellitus, Type 2/complications , Gram-Positive Bacterial Infections/complications , Peritonitis/complications , Acalculous Cholecystitis/drug therapy , Acalculous Cholecystitis/microbiology , Acalculous Cholecystitis/surgery , Anti-Bacterial Agents/therapeutic use , Bile/microbiology , Cholecystectomy , Cholecystitis, Acute , Diabetes Mellitus, Type 2/drug therapy , Diabetes Mellitus, Type 2/microbiology , Diabetes Mellitus, Type 2/surgery , Gram-Positive Bacterial Infections/drug therapy , Gram-Positive Bacterial Infections/microbiology , Gram-Positive Bacterial Infections/surgery , Humans , Imipenem/therapeutic use , Lactobacillus plantarum/drug effects , Lactobacillus plantarum/growth & development , Lactobacillus plantarum/isolation & purification , Male , Middle Aged , Peritonitis/drug therapy , Peritonitis/microbiology , Peritonitis/surgery , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...